RTW Investments’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

RTW Investments’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-37,062	Closed	-$7.55M	–	123
2021 Q4	$7.55M	Sell	37,062 -438	-1%	-$109K	0.11%	88
2021 Q3	$12.1M	Hold	37,500	–	–	0.18%	74
2021 Q2	$9.74M	Buy	37,500 +12,500	+50%	+$3.81M	0.15%	75
2021 Q1	$9.65M	Hold	25,000	–	–	0.15%	71
2020 Q4	$10.5M	Buy	+25,000	New	+$7.88M	0.18%	68

Other funds holding VINC

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SRC

Sage Rhino Capital Menlo Park, California $535M AUM 24.07% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments's VINC Position: Q1 2022 in Review

RTW Investments sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q1 2022, closing a stake of 37,062 shares — an estimated $7.55M sold.

RTW Investments first reported a position in VINC in Q4 2020 and held it in 5 quarters. The position peaked at $12.1M in Q3 2021. 67 funds tracked by Wall St. Rank hold VINC as of Q1 2022.

RTW Investments reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
RTW Investments sold 37,062 Vincerx Pharma, Inc. Common Stock shares in Q1 2022, an estimated $7.55M.
RTW Investments first reported a position in Vincerx Pharma, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
RTW Investments's Vincerx Pharma, Inc. Common Stock position peaked at $12.1M in Q3 2021.
67 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q1 2022.

Based on RTW Investments's 13F filing for Q1 2022, filed 16 May 2022.